As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find ...

AB Science AbbVie Abcam Abingworth Abivax Ablynx AC Immune Actelion Acticor Biotech Adaptimmune ADC Therapeutics Adocia Affibody Affimed Agendia AiCuris Allergan ...

PMOS, formerly PCOS, still has no approved dedicated drug. Discover the new PMOS treatments in development, from GLP-1s to ...

As BIOSPAIN 2026 comes to end, delve into what as been at the center of this edition's discussion: what comes after we have ...

Brain biomarkers were long hard to pin down. See how new Parkinson's and Alzheimer's biomarkers are changing that.

Learn how to choose and integrate automated liquid handling solutions while overcoming challenges and supporting flexible lab ...

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability ...

The companies ADARx Pharmaceuticals, Electra Therapeutics, and Enveda bagged the biggest biotech funding rounds overall in ...

Look into Spain's biotech, an ecosystem that has matured and transforms promissing science into ventures but faces challenges ...

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

Discover biotech and big pharma’s emerging interest in developing macrocyclic drugs for cardiometabolic diseases.